Quick answers about LibiTight

LibiTight Femme Gel is a non-hormonal, multifunctional vaginal gel developed by Goodness Care in Jordan. It provides hydration to vaginal tissues, supports tissue integrity, increases comfort, and offers temporary tightening — addressing common concerns related to vaginal dryness, menopause, postpartum recovery, and intimate discomfort.

No. LibiTight is completely non-hormonal. Its formulation relies on actives including hyaluronic acid, chamomile extract, allantoin, L-arginine, and potassium alum to deliver its effects without introducing any hormones into the body. This makes it suitable for women who cannot use, or prefer to avoid, hormonal treatments.

LibiTight is designed for adult women experiencing vaginal dryness, discomfort, or loss of vaginal tone — whether due to menopause, postpartum changes, hormonal fluctuations, certain medications, or other natural causes. If you have specific medical conditions, are pregnant, or are unsure whether LibiTight is appropriate for you, consult your healthcare provider before use.

LibiTight is currently available in Jordan, Kuwait, Qatar, and Palestine through licensed pharmacies. We are actively expanding into additional markets across the Middle East, North Africa, and Sub-Saharan Africa. For purchase inquiries in your country, contact us through the Contact page, or order via the Goodness Care online shop where applicable.

LibiTight is formulated for ongoing use. Its non-hormonal formulation, dermatologically-tested ingredients, and pH-balanced design make it suitable for regular use as part of an intimate care routine. As with any product, discontinue use if you experience irritation, unusual symptoms, or any reaction, and consult your healthcare provider.

Apply a small amount of gel to the vaginal opening and inner walls using clean fingers or the applicator provided. A pea-sized amount is typically sufficient, though you may adjust to your comfort. Wash your hands before and after application.

LibiTight can be used daily or as needed. Many women begin with daily applications to build initial hydration, then reduce to two or three times per week for maintenance. Use it whenever you experience dryness or discomfort, including before intimate activity.

Hydration and comfort improvements are typically felt within the first few applications. The tightening effect is temporary and most noticeable shortly after application. Consistent use over several weeks tends to support more sustained comfort for most users.

LibiTight's water-based formulation is compatible with latex and polyurethane condoms. If you use other latex contraceptive devices, always check the device packaging, as some advise against using gel-based products alongside them.

Yes. Many women apply LibiTight shortly before intimate activity to improve comfort and lubrication. It is not a contraceptive and does not provide protection against sexually transmitted infections.

A pea-sized amount is a common starting point. You may use a little more if needed for full coverage and comfort. Avoid using excessive amounts — a thin, even application provides the same benefits as a larger one.

LibiTight is designed to address vaginal dryness and discomfort, including those associated with menopause. Its hyaluronic acid and allantoin content supports tissue hydration and comfort. LibiTight does not treat menopause itself or alter hormone levels.

LibiTight may support vaginal comfort during postpartum recovery, a time when dryness and changes in vaginal tone are common. If you are in the immediate postpartum period, have had surgery, or have any unhealed tissue, consult your healthcare provider before use.

LibiTight's hydrating and lubricating formulation is designed to reduce friction and discomfort associated with vaginal dryness — a common contributing factor to painful intimacy. If your discomfort is significant or persistent, a healthcare professional can help identify whether underlying causes need additional attention.

If you are pregnant, consult your healthcare provider before using any vaginal product, including LibiTight. This is standard guidance for all intravaginal preparations during pregnancy, not an indication of a specific concern with LibiTight.

LibiTight's non-hormonal formulation is appropriate for breastfeeding mothers. The topical, hormone-free profile means active ingredients aren't absorbed systemically in amounts that would affect milk supply or composition. Breastfeeding-related vaginal dryness — driven by lower estrogen levels in the postpartum period — is one of the situations LibiTight is designed to address. If you have specific concerns or are in the first six weeks postpartum, discuss with your healthcare provider.

LibiTight is a topical gel applied vaginally and is not expected to interact with systemic medications. If you are using other vaginal preparations, or have questions about compatibility with a specific medication or treatment, consult your healthcare provider.

LibiTight is a non-hormonal complement to intimate care, not a replacement for prescribed medical treatment. If you are currently on, or considering, hormonal vaginal therapy, speak with your healthcare provider about how a non-hormonal gel might fit alongside — not instead of — their recommendations.

LibiTight contains hyaluronic acid, chamomile extract, allantoin, L-arginine, and potassium alum — ingredients with established safety profiles in personal care formulations. The gel is dermatologically tested and formulated for use on sensitive vaginal tissue. Review the full ingredient list if you have known allergies or sensitivities.

LibiTight is formulated with sensitive tissue in mind. Its pH-balanced, dermatologically tested formulation is free from fragrances and harsh chemicals. If you know you are sensitive to any listed ingredient, perform a small external patch test first, or consult your healthcare provider before use.

Discontinue use and rinse the area with clean water if you experience any irritation, itching, or unusual discomfort after application. If symptoms persist or worsen, consult your healthcare provider. Some individuals may be sensitive to certain ingredients, even those with established safety profiles.

Yes. LibiTight is dermatologically tested and formulated to be appropriate for use on the sensitive vaginal epithelium. It is pH-balanced to support the natural vaginal environment.

LibiTight is well tolerated by most users. As with any topical product applied to sensitive tissue, a small number of users may experience mild, transient reactions such as a brief warm or tingling sensation. Discontinue use and consult a healthcare provider if any reaction persists, worsens, or is accompanied by unusual discharge or symptoms.

LibiTight Femme Gel combines five actives to deliver hydration, tissue support, comfort, and temporary tightening. Hyaluronic acid provides immediate and sustained hydration to vaginal tissues. Chamomile extract contributes anti-inflammatory and soothing effects. Allantoin supports tissue regeneration and barrier function. L-arginine acts as a vasodilator promoting local circulation. Potassium alum provides a temporary astringent effect for tightening. The combined formulation is non-hormonal and works topically without systemic absorption.

The clinical evidence base supports the individual actives in LibiTight's formulation. Published studies on hyaluronic acid, chamomile extract, and L-arginine — in contexts including vaginal moisturization, mucosal healing, and circulation support — are summarized on the Clinical Evidence page. Note that the formulation as a whole has not been studied in randomized controlled trials; the evidence describes the actives individually. Detailed citations and study designs are available in the Technical File available to healthcare professionals.

LibiTight is generally well-tolerated. The non-hormonal formulation, dermatologically-tested ingredients, and pH-balanced design support routine clinical use. The formal contraindication is known hypersensitivity to any listed ingredient: hyaluronic acid, chamomile extract, allantoin, L-arginine, or potassium alum. Mild temporary tingling or warmth on first application is the most commonly reported tolerability observation; persistent irritation should prompt discontinuation. No known interactions with systemic hormonal therapies, oral contraceptives, or other systemic medications.

LibiTight Femme Gel is classified as a cosmetic intimate care product in its current markets (Jordan, Kuwait, Qatar, Palestine). Classification may vary in additional markets; the Goodness Care regulatory team can provide jurisdiction-specific documentation for prescribers and pharmacy partners. Full regulatory documentation including Certificate of Analysis and Free Sale Certificates (where available) is provided through the medical affairs channel.

Position LibiTight as a non-hormonal option for women experiencing vaginal dryness, postpartum or breastfeeding-related comfort concerns, or menopausal symptoms who cannot use or prefer to avoid hormonal therapies. Set realistic expectations: hydration improvement is typically immediate; tissue support and comfort improvement build over weeks of consistent use. The temporary tightening effect is bounded and does not replace pelvic floor rehabilitation for significant changes. Encourage continuation if well-tolerated; advise discontinuation if irritation occurs.

Samples for clinical demonstration are available on request — contact medical affairs via WhatsApp (+962 78 290 4344). The full Technical File, including ingredient mechanisms, safety data, clinical evidence summary, and regulatory documentation, is available by email to khaled@goodnesscare.com. The Healthcare Professionals page lists these resources directly.

Minimum opening order is determined per market based on registration requirements, market size, and the agreed distribution territory. This is discussed during initial commercial conversations and confirmed in the distribution agreement. Contact us through the inquiry form on the Partner page to begin the conversation.

Exclusive territory rights are available for committed partners. Exclusivity is contingent on registration responsibility, minimum opening order, annual targets, and ongoing distribution performance. The specific structure is discussed and agreed during initial commercial conversations. There is no standard one-size-fits-all template — terms reflect the partnership's commitments and the market opportunity.

Registration responsibility depends on the structure of the partnership. Goodness Care provides a complete documentation pack — product documents, certificates, formulas, artwork, technical files, Certificates of Analysis, and Free Sale Certificates where available — along with guidance from our regulatory team. The actual registration process is typically the responsibility of the local distributor in their market, leveraging the documentation package we provide.

We provide ready-to-deploy assets in Arabic and English: brochures, pharmacy flyers, product images, social media content, WhatsApp content, and pharmacy-facing materials. Training resources are structured for sales teams, particularly for LibiTight: product positioning, ingredient mechanisms, usage guidance, customer journey mapping, and competitive landscape. Training is delivered virtually or via our training PDF. Co-branding options are available for localized markets.

The Goodness Care portfolio includes LibiTight Femme Gel, Scarless, UlcerMagic, AlphaMale, D-Omega Drops, Digestive Enzymes, Krill Oil, and Sweat Guard. Distributors can build a multi-product portfolio rather than depending on a single SKU. Each product addresses a specific clinical or consumer need with formulations designed to compete on quality with established global brands. The About page describes the portfolio in detail.

The inquiry form on the Partner page is the primary intake channel — share your territory, company background, and the products that fit your portfolio. We respond within two business days from our team in Amman. For faster initial contact, WhatsApp (+962 78 290 4344) reaches the commercial team directly. We typically follow inquiry with an introductory call and detailed materials review before commercial discussion.